Fig.3

Relationship between clinical characteristics and GSS. a ER status vs GSS; Mann–Whitney U test. b PR status vs GSS; Mann–Whitney U test. c HER2 status vs GSS; Mann–Whitney U test. d Molecular subtyping vs GSS; Mann–Whitney U test. e Ki- 67 index vs GSS; Mann–Whitney U test. f Histopathological grade vs GSS; Mann–Whitney U test. ER, estrogen receptor; PR, progesterone receptor; HER2, human epidermal growth factor receptor 2; TNBC, triple-negative breast cancer